Tranexamic acid is emerging as a useful option for a number of clinical indications, by virtue of its anti-fibrinolytic properties that allow better haemostasis and lesser blood loss. Herein, the authors have attempted to summarize the existing evidence on the possible role of tranexamic acid in brain tumour surgeries.
|Number of pages||3|
|Journal||JPMA. The Journal of the Pakistan Medical Association|
|Publication status||Published - 1 Apr 2020|
- Tranexamic acid, brain tumor, coagulation, hemostasis.